KMID : 0359920080270030280
|
|
Korean Journal of Nephrology 2008 Volume.27 No. 3 p.280 ~ p.289
|
|
The Effect of FR167653, p38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor, on the Expression of Slit Diaphragm-Associated Proteins in Experimental Diabetic Nephropathy
|
|
Ryu Dong-Ryeol
Yoo Tae-Hyun Jung Dong-Sub Kwak Seung-Jae Park Je-hyun Lee Sun-Ha Li Jin-Ji Ryu Jung-Hwa Yu Min-A Kim Seung-Jung Kang Duk-Hee Choi Kyu-Bok Yoon Kyun-Il Han Dae-Suk Kang Shin-Wook
|
|
Abstract
|
|
|
Purpose: This study was undertaken to investigate the effect of a p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, FR167653, on urinary albumin excretion and on the expression of slit diaphragm-associated proteins in diabetic rats.
Methods: Thirty-two Sprague-Dawley rats were injected with diluent [control (C), N=16] or streptozotocin intraperitoneally (DM, N=16). Eight rats from each group were treated with 5 mg/kg/day FR 167653 (C+FR, DM+FR) for 6 weeks. At the time of sacrifice, 24-hour urinary albumin excretion was determined by ELISA. Glomerular nephrin, P-cadherin, and ZO-1 mRNA and protein expression were determined by real-time PCR and Western blot, respectively, with sieved glomeruli.
Results: Urinary albumin excretion was significantly higher in DM compared to C rats, and this increase in albuminuria was significantly inhibited by the administration of FR167653 in DM rats. Glomerular phospho-p38 MAPK protein expression was significantly increased in DM rats compared to C rats, and FR167653 treatment significantly attenuated the increase in phospho-p38 MAPK expression in DM glomeruli. Nephrin mRNA and protein expression were higher in 6-week DM compared to C glomeruli, and these increases were significantly abrogated with FR167653 treatment in DM rats. In contrast, FR167653 had no effects on the decrease in P-cadherin expression and the increase in ZO-1 expression observed in DM glomeruli.
Conclusion: These findings suggest that FR167653, a p38 MAPK inhibitor, reduce the amount of albuminuria in early diabetic nephropathy, and this anti-proteinuric effect seems to be related with the change of glomerular nephrin expression.
|
|
KEYWORD
|
|
Diabetic nephropathy, p38 mitogen-activated protein kinases, FR167653
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|